Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Long-term follow-up of nailfold videocapillaroscopic microvascular parameters in mixed connective tissue disease versus systemic sclerosis patients: a retrospective cohort study.

Paolino S, Ferrari G, Pizzorni C, Patanè M, Smith V, Cutolo M, Sulli A.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):102-107. Epub 2019 Oct 3.

2.

Lower urinary tract symptoms in systemic sclerosis: a detailed investigation.

Pacini G, Paolino S, CleliaTrombetta A, Goegan F, Pizzorni C, Alessandri E, Patanè M, Gotelli E, Ferrari G, Cattelan F, Ghio M, Casabella A, Smith V, Cutolo M.

Rheumatology (Oxford). 2019 Oct 5. pii: kez438. doi: 10.1093/rheumatology/kez438. [Epub ahead of print]

PMID:
31586421
3.

Interactions between microbiota, diet/nutrients and immune/inflammatory response in rheumatic diseases: focus on rheumatoid arthritis.

Paolino S, Pacini G, Patanè M, Alessandri E, Cattelan F, Goegan F, Pizzorni C, Gotelli E, Cutolo M.

Reumatologia. 2019;57(3):151-157. doi: 10.5114/reum.2019.86425. Epub 2019 Jun 28. Review.

4.

Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon.

Ruaro B, Smith V, Sulli A, Pizzorni C, Tardito S, Patané M, Paolino S, Cutolo M.

Front Pharmacol. 2019 Apr 16;10:360. doi: 10.3389/fphar.2019.00360. eCollection 2019.

5.

Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.

Ruaro B, Soldano S, Smith V, Paolino S, Contini P, Montagna P, Pizzorni C, Casabella A, Tardito S, Sulli A, Cutolo M.

Rheumatol Int. 2019 Aug;39(8):1369-1376. doi: 10.1007/s00296-019-04315-7. Epub 2019 May 6.

PMID:
31056725
6.

Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study.

Ruaro B, Pizzorni C, Paolino S, Alessandri E, Sulli A.

Front Pharmacol. 2019 Apr 4;10:293. doi: 10.3389/fphar.2019.00293. eCollection 2019.

7.

Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.

Ruaro B, Pizzorni C, Paolino S, Smith V, Ghio M, Casabella A, Alessandri E, Patané M, Sulli A, Cutolo M.

Microvasc Res. 2019 Sep;125:103874. doi: 10.1016/j.mvr.2019.04.004. Epub 2019 Apr 8.

PMID:
30974112
8.

The impact of transducer frequency in ultrasound evaluation of subclinical skin involvement in limited cutaneous systemic sclerosis patients.

Ruaro B, Sulli A, Smith V, Santiago T, da Silva JAP, Pizzorni C, Paolino S, Alessandri E, Cutolo M.

Clin Exp Rheumatol. 2019 Jul-Aug;37 Suppl 119(4):147-148. Epub 2019 Feb 25. No abstract available.

9.

Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the Trabecular Bone Score (TBS).

Ruaro B, Casabella A, Paolino S, Pizzorni C, Ghio M, Seriolo C, Molfetta L, Odetti P, Smith V, Cutolo M.

Clin Rheumatol. 2018 Nov;37(11):3057-3062. doi: 10.1007/s10067-018-4322-9. Epub 2018 Oct 6.

PMID:
30291470
10.

A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.

Trombetta AC, Soldano S, Contini P, Tomatis V, Ruaro B, Paolino S, Brizzolara R, Montagna P, Sulli A, Pizzorni C, Smith V, Cutolo M.

Respir Res. 2018 Sep 24;19(1):186. doi: 10.1186/s12931-018-0891-z.

11.

Nailfold capillaroscopy-how many fingers should be examined to detect abnormality?

Dinsdale G, Roberts C, Moore T, Manning J, Berks M, Allen J, Anderson ME, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Rheumatology (Oxford). 2019 Feb 1;58(2):284-288. doi: 10.1093/rheumatology/key293.

PMID:
30247696
12.

Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay.

Cutolo M, Soldano S, Montagna P, Trombetta AC, Contini P, Ruaro B, Sulli A, Scabini S, Stratta E, Paolino S, Pizzorni C, Smith V, Brizzolara R.

Arthritis Res Ther. 2018 Jul 27;20(1):157. doi: 10.1186/s13075-018-1652-6.

13.

Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis.

Soldano S, Trombetta AC, Contini P, Tomatis V, Ruaro B, Brizzolara R, Montagna P, Sulli A, Paolino S, Pizzorni C, Smith V, Cutolo M.

Ann Rheum Dis. 2018 Dec;77(12):1842-1845. doi: 10.1136/annrheumdis-2018-213648. Epub 2018 Jul 16. No abstract available.

14.

Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients.

Pizzorni C, Cutolo M, Sulli A, Ruaro B, Trombetta AC, Ferrari G, Pesce G, Smith V, Paolino S.

Clin Rheumatol. 2018 Oct;37(10):2723-2729. doi: 10.1007/s10067-018-4211-2. Epub 2018 Jul 13.

PMID:
30006917
15.

Correlation between bone quality and microvascular damage in systemic sclerosis patients.

Ruaro B, Casabella A, Paolino S, Pizzorni C, Alessandri E, Seriolo C, Botticella G, Molfetta L, Odetti P, Smith V, Cutolo M.

Rheumatology (Oxford). 2018 Sep 1;57(9):1548-1554. doi: 10.1093/rheumatology/key130.

PMID:
29788459
16.

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.

Cutolo M, Ruaro B, Montagna P, Brizzolara R, Stratta E, Trombetta AC, Scabini S, Tavilla PP, Parodi A, Corallo C, Giordano N, Paolino S, Pizzorni C, Sulli A, Smith V, Soldano S.

Arthritis Res Ther. 2018 May 2;20(1):77. doi: 10.1186/s13075-018-1577-0.

17.

Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis.

Cutolo M, Trombetta AC, Melsens K, Pizzorni C, Sulli A, Ruaro B, Paolino S, Deschepper E, Smith V.

Microcirculation. 2018 May;25(4):e12447. doi: 10.1111/micc.12447.

PMID:
29527781
18.

The assessment of nailfold capillaries: comparison of dermoscopy and nailfold videocapillaroscopy.

Dinsdale G, Peytrignet S, Moore T, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Rheumatology (Oxford). 2018 Jun 1;57(6):1115-1116. doi: 10.1093/rheumatology/key018. No abstract available.

PMID:
29447411
19.

Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases.

Cutolo M, Melsens K, Herrick AL, Foeldvari I, Deschepper E, De Keyser F, Distler O, Ingegnoli F, Mostmans Y, Müller-Ladner U, Pizzorni C, Riccieri V, Ruaro B, Sulli A, Trombetta AC, Vanhaecke A, Smith V; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Rheumatology (Oxford). 2018 Apr 1;57(4):757-759. doi: 10.1093/rheumatology/kex460. Review. No abstract available.

20.

Plantar pain is not always fasciitis.

Romano N, Fischetti A, Prono V, Migone S, Barbieri F, Pizzorni C, Garlaschi G, Cimmino MA.

Reumatismo. 2017 Dec 21;69(4):189-190. doi: 10.4081/reumatismo.2017.989.

21.

Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques.

Ruaro B, Sulli A, Smith V, Pizzorni C, Paolino S, Alessandri E, Cutolo M.

Reumatismo. 2017 Dec 21;69(4):147-155. doi: 10.4081/reumatismo.2017.959. Review.

22.

Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study.

Pizzorni C, Sulli A, Paolino S, Ruaro B, Smith V, Trombetta AC, Cutolo M.

J Rheumatol. 2017 Dec;44(12):1941-1942. doi: 10.3899/jrheum.170485. No abstract available.

PMID:
29196550
23.

Glucocorticoid management in rheumatoid arthritis: morning or night low dose?

Paolino S, Cutolo M, Pizzorni C.

Reumatologia. 2017;55(4):189-197. doi: 10.5114/reum.2017.69779. Epub 2017 Aug 31. Review.

24.

Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis.

Ruaro B, Paolino S, Pizzorni C, Cutolo M, Sulli A.

Reumatismo. 2017 Sep 21;69(3):134-136. doi: 10.4081/reumatismo.2017.986.

25.

Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis.

Zentilin P, Savarino V, Marabotto E, Murdaca G, Sulli A, Pizzorni C, Puppo F, Savarino E.

Semin Arthritis Rheum. 2018 Feb;47(4):569-574. doi: 10.1016/j.semarthrit.2017.08.004. Epub 2017 Aug 9.

PMID:
28870413
26.

Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients.

Ruaro B, Sulli A, Pizzorni C, Paolino S, Smith V, Alessandri E, Trombetta AC, Alsheyyab J, Cutolo M.

Microvasc Res. 2018 Jan;115:28-33. doi: 10.1016/j.mvr.2017.08.004. Epub 2017 Aug 20.

PMID:
28834709
27.

Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments.

Trombetta AC, Smith V, Gotelli E, Ghio M, Paolino S, Pizzorni C, Vanhaecke A, Ruaro B, Sulli A, Cutolo M.

PLoS One. 2017 Jun 9;12(6):e0179062. doi: 10.1371/journal.pone.0179062. eCollection 2017.

28.

Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy.

Dinsdale G, Moore T, O'Leary N, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Microvasc Res. 2017 Sep;113:56-59. doi: 10.1016/j.mvr.2017.05.003. Epub 2017 May 8.

PMID:
28495471
29.

Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.

PLoS One. 2017 Mar 30;12(3):e0175238. doi: 10.1371/journal.pone.0175238. eCollection 2017.

30.

Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis.

Sulli A, Ruaro B, Smith V, Paolino S, Pizzorni C, Pesce G, Cutolo M.

Arthritis Res Ther. 2017 Mar 20;19(1):61. doi: 10.1186/s13075-017-1270-8.

31.

Intra-and inter-observer reliability of nailfold videocapillaroscopy - A possible outcome measure for systemic sclerosis-related microangiopathy.

Dinsdale G, Moore T, O'Leary N, Tresadern P, Berks M, Roberts C, Manning J, Allen J, Anderson M, Cutolo M, Hesselstrand R, Howell K, Pizzorni C, Smith V, Sulli A, Wildt M, Taylor C, Murray A, Herrick AL.

Microvasc Res. 2017 Jul;112:1-6. doi: 10.1016/j.mvr.2017.02.001. Epub 2017 Feb 2.

PMID:
28163035
32.

Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.

Soldano S, Paolino S, Pizzorni C, Trombetta AC, Montagna P, Brizzolara R, Corallo C, Giordano N, Sulli A, Cutolo M.

Clin Exp Rheumatol. 2017 May-Jun;35(3):484-493. Epub 2017 Jan 27.

PMID:
28134077
33.

Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis.

Pizzorni C, Giampetruzzi AR, Mondino C, Facchiano A, Abeni D, Paolino S, Ruaro B, Smith V, Sulli A, Cutolo M.

Microvasc Res. 2017 May;111:20-24. doi: 10.1016/j.mvr.2016.12.003. Epub 2016 Dec 16.

PMID:
27989404
34.

Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.

Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.

PLoS One. 2016 Nov 15;11(11):e0166433. doi: 10.1371/journal.pone.0166433. eCollection 2016. Erratum in: PLoS One. 2017 Mar 30;12 (3):e0175238.

35.

Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis.

Trombetta AC, Pizzorni C, Ruaro B, Paolino S, Sulli A, Smith V, Cutolo M.

J Rheumatol. 2016 Nov;43(11):2033-2041. Epub 2016 Oct 1.

36.

Primary Raynaud's phenomenon and nailfold videocapillaroscopy: age-related changes in capillary morphology.

Pizzorni C, Sulli A, Smith V, Ruaro B, Trombetta AC, Cutolo M, Paolino S.

Clin Rheumatol. 2017 Jul;36(7):1637-1642. doi: 10.1007/s10067-016-3442-3. Epub 2016 Oct 8.

PMID:
27722973
37.

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

Smith V, Pizzorni C, Riccieri V, Decuman S, Brusselle G, DE Pauw M, Deschepper E, Piette Y, Ruaro B, Sulli A, Vandecasteele E, Melsens K, DE Keyser F, Cutolo M.

J Rheumatol. 2016 May;43(5):995-6. doi: 10.3899/jrheum.151018. No abstract available.

PMID:
27134280
38.

Systemic sclerosis: markers and targeted treatments.

Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V.

Acta Reumatol Port. 2016 Jan-Mar;41(1):18-25. Review.

39.

Capillaroscopy 2016: new perspectives in systemic sclerosis.

Pizzorni C, Sulli A, Smith V, Lladó A, Paolino S, Cutolo M, Ruaro B.

Acta Reumatol Port. 2016 Jan-Mar;41(1):8-14. Review.

40.

Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Smith V, Thevissen K, Trombetta AC, Pizzorni C, Ruaro B, Piette Y, Paolino S, De Keyser F, Sulli A, Melsens K, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Microcirculation. 2016 Jul;23(5):364-72. doi: 10.1111/micc.12281. Review.

PMID:
27086648
41.

Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages.

Cutolo M, Paolino S, Pizzorni C, Sulli A, Seriolo B, Cimmino MA, Montagna P, Soldano S, Contini P, Brizzolara R.

Clin Exp Rheumatol. 2016 May-Jun;34(3):500-6. Epub 2016 Mar 3.

PMID:
26940199
42.

Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients.

Ruaro B, Sulli A, Pizzorni C, Paolino S, Smith V, Cutolo M.

Microvasc Res. 2016 May;105:119-24. doi: 10.1016/j.mvr.2016.02.007. Epub 2016 Feb 18.

PMID:
26907637
43.

Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern.

Trombetta AC, Smith V, Pizzorni C, Meroni M, Paolino S, Cariti C, Ruaro B, Sulli A, Cutolo M.

J Rheumatol. 2016 Mar;43(3):599-606. doi: 10.3899/jrheum.150900. Epub 2016 Feb 1.

PMID:
26834221
44.

CTLA-4 blockade in the treatment of rheumatoid arthritis: an update.

Cutolo M, Sulli A, Paolino S, Pizzorni C.

Expert Rev Clin Immunol. 2016;12(4):417-25. doi: 10.1586/1744666X.2016.1133295. Epub 2016 Jan 22. Review.

PMID:
26679631
45.

Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients.

Ruaro B, Sulli A, Smith V, Paolino S, Pizzorni C, Cutolo M.

Microvasc Res. 2015 Sep;101:82-5. doi: 10.1016/j.mvr.2015.06.009. Epub 2015 Jun 30.

PMID:
26142117
46.

CTLA4-Ig/CD86 interactions in cultured human endothelial cells: effects on VEGFR-2 and ICAM1 expression.

Cutolo M, Montagna P, Soldano S, Contini P, Paolino S, Pizzorni C, Seriolo B, Sulli A, Brizzolara R.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):250-4. Epub 2015 Apr 9.

PMID:
25896473
47.

Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D.

Piantoni S, Andreoli L, Scarsi M, Zanola A, Dall'Ara F, Pizzorni C, Cutolo M, Airò P, Tincani A.

Lupus. 2015 Apr;24(4-5):490-8. doi: 10.1177/0961203314559090.

PMID:
25801892
48.

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.

Cutolo M, Spies CM, Buttgereit F, Paolino S, Pizzorni C.

Arthritis Res Ther. 2014 Nov 13;16 Suppl 2:S1. doi: 10.1186/ar4685. Review.

49.

Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts.

Cutolo M, Montagna P, Brizzolara R, Smith V, Alessandri E, Villaggio B, Sulli A, Tavilla PP, Pizzorni C, Soldano S.

J Rheumatol. 2015 Mar;42(3):456-63. doi: 10.3899/jrheum.141070. Epub 2015 Jan 15.

PMID:
25593238
50.

Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis.

Ruaro B, Smith V, Sulli A, Decuman S, Pizzorni C, Cutolo M.

Korean J Intern Med. 2015 Jan;30(1):1-5. doi: 10.3904/kjim.2015.30.1.1. Epub 2014 Dec 30. Review.

Supplemental Content

Loading ...
Support Center